Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are New Antiretroviral Treatments Increasing the Risk of Weight Gain?
Shahini Shah, Laura Hindley, Andrew Hill
Drugs (2021) Vol. 81, Iss. 3, pp. 299-315
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications
Nomathemba Chandiwana, Mark J. Siedner, Vincent C. Marconi, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 2, pp. e478-e487
Open Access | Times Cited: 32
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study
Thokozile R. Malaba, Irene Nakatudde, Kenneth Kintu, et al.
The Lancet HIV (2022) Vol. 9, Iss. 8, pp. e534-e543
Open Access | Times Cited: 36
Cardiovascular toxicity of contemporary antiretroviral therapy
Alinda G. Vos, François Venter
Current Opinion in HIV and AIDS (2021) Vol. 16, Iss. 6, pp. 286-291
Open Access | Times Cited: 40
Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes
Kenza Ngono Ayissi, Jennifer Gorwood, Laura Pelletier, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1841-1841
Open Access | Times Cited: 27
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
Theodore Ruel, Edward P. Acosta, Jessica P. Liu, et al.
The Lancet HIV (2022) Vol. 9, Iss. 5, pp. e332-e340
Open Access | Times Cited: 26
Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy
Carlotta Riebensahm, Annalisa Berzigotti, Bernard Surial, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 25
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda
Giovanni Guaraldi, Paolo Bonfanti, Antonio Di Biagio, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania
Monica Kahabuka, Yimtubezinash Woldeamanuel, Peter M. Mbelele, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Body image among people living with HIV: A systematic review and narrative synthesis
Katarzyna Drabarek, Marcin Rzeszutek, Cecylia Poncyliusz, et al.
Body Image (2025) Vol. 53, pp. 101880-101880
Closed Access
Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV
Leena Zino, Jurjen S. Kingma, Catia Marzolini, et al.
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 5, pp. 619-635
Open Access | Times Cited: 16
Doravirine Plus Integrase Strand Transfer Inhibitors as a 2-Drug Treatment–Switch Strategy in People Living with HIV: The Real-Life DORINI Multicentric Cohort Study
Mariacristina Poliseno, Maria Mazzitelli, A Narducci, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2023) Vol. 94, Iss. 3, pp. 235-243
Closed Access | Times Cited: 9
Effect of dolutegravir-based versus efavirenz-based antiretroviral therapy on excessive weight gain in adult treatment-naïve HIV patients at Matsanjeni health center, Eswatini: a retrospective cohort study
Didier M. Mukuna, Tom Decroo, Clara M. Nyapokoto
AIDS Research and Therapy (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Risks of metabolic syndrome in the ADVANCE and NAMSAL trials
Tamara Tovar Sanchez, Mireille Mpoudi-Etame, Charles Kouanfack, et al.
Frontiers in Reproductive Health (2023) Vol. 5
Open Access | Times Cited: 8
Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States
Bruno Émond, Carmine Rossi, Aurélie Côté‐Sergent, et al.
Current Medical Research and Opinion (2021) Vol. 38, Iss. 2, pp. 287-298
Open Access | Times Cited: 17
Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell lines
Julien De Greef, Mathilde Akue, Nadtha Panin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Weight Change When Initiating, Switching to, and Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV
Warittha Tieosapjaroen, Eric P. F. Chow, Christopher K. Fairley, et al.
AIDS Patient Care and STDs (2023) Vol. 37, Iss. 3, pp. 131-137
Closed Access | Times Cited: 6
Role of the pharmacist caring for people at risk of or living with HIV in Canada
Stacey Tkachuk, Erin Ready, Shanna Chan, et al.
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (2024) Vol. 157, Iss. 5, pp. 218-239
Open Access | Times Cited: 2
Effect of metabolic status on response to SIV infection and antiretroviral therapy in nonhuman primates
Gabriela M. Webb, Kristin A. Sauter, Diana Takahashi, et al.
JCI Insight (2024) Vol. 9, Iss. 18
Open Access | Times Cited: 2
Concentration–response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy
Rulan Griesel, Aida N. Kawuma, Roeland E. Wasmann, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 3, pp. 883-893
Open Access | Times Cited: 13
Weight Gain in Overweight and Obese People with HIV—The OBHIV Cohort
Lucia Taramasso, Silvia Dettori, Elena Ricci, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1211-1211
Open Access | Times Cited: 1
Switching from Tenofovir Disoproxil to Tenofovir Alafenamide Fumarate: Impact on Cardiovascular Risk and Lipid Profile in People Living with HIV, an Observational Study
Charalampos D. Moschopoulos, Konstantinos Protopapas, Κonstantinos Thomas, et al.
AIDS Research and Human Retroviruses (2022) Vol. 39, Iss. 2, pp. 68-75
Closed Access | Times Cited: 6
Roadmap for Achieving Universal Antiretroviral Treatment
Simiso Sokhela, Samanta Tresha Lalla‐Edward, Mark J. Siedner, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 63, Iss. 1, pp. 99-117
Open Access | Times Cited: 3
Changes in Leptin to Adiponectin Ratio After Antiretroviral Therapy: A Pilot Observational Study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Current HIV Research (2023) Vol. 21, Iss. 3, pp. 185-191
Closed Access | Times Cited: 3
Weight gain after antiretroviral therapy initiation in people living with HIV in the United States: analyses of electronic medical records and prescription claims
Xiaohui Zhao, Girish Prajapati, Jenny Tse, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 7, pp. 997-1006
Open Access | Times Cited: 3
HIV : the changing paradigm
Sian Raubinger, Frederick J. Lee, Angie N. Pinto
Internal Medicine Journal (2022) Vol. 52, Iss. 4, pp. 542-549
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top